(Q39750500)

14 September 2017

title

Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype (English)

1 reference

14 September 2017

9

1 reference

14 September 2017

Carmen Ghilardi

2

0 references

Antonietta Silini

object named as

Antonietta Silini

1

0 references

Antonella Naldini

object named as

Antonella Naldini

7

0 references

Fabio Carraro

object named as

Fabio Carraro

6

0 references

author name string

Camilla Ardinghi

3

1 reference

14 September 2017

Sergio Bernasconi

4

1 reference

14 September 2017

Paolo Oliva

5

1 reference

14 September 2017

Maria Rosa Bani

8

1 reference

14 September 2017

publication date

20 December 2009

1 reference

Clinical & Experimental Metastasis

14 September 2017

published in

1 reference

14 September 2017

volume

27

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

43-53

1 reference

Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells

14 September 2017

cites work

1 reference

12 December 2020

Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells

1 reference

12 December 2020

Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43.

1 reference

12 December 2020

Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF.

1 reference

12 December 2020

Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin

1 reference

12 December 2020

PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.

1 reference

12 December 2020

Proteinase-activated receptors.

1 reference

12 December 2020

Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma

1 reference

12 December 2020

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

12 December 2020

Identification of novel vascular markers through gene expression profiling of tumor-derived endothelium

1 reference

12 December 2020

Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma

1 reference

12 December 2020

Gene regulation in melanoma progression by the AP-2 transcription factor

1 reference

12 December 2020

Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis

1 reference

12 December 2020

Effect of Interleukin-1-beta on Metastasis Formation in Different Tumor Systems

1 reference

12 December 2020

Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis

1 reference

12 December 2020

The role of altered cell-cell communication in melanoma progression

1 reference

12 December 2020

Human melanoma: development and progression

1 reference

12 December 2020

'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression

1 reference

12 December 2020

Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.

1 reference

12 December 2020

Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.

1 reference

12 December 2020

The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells

1 reference

12 December 2020

Thrombin signalling and protease-activated receptors

1 reference

12 December 2020

The pattern of Protease Activated Receptor 1 (PAR1) expression in endometrial carcinoma

1 reference

12 December 2020

Double transfection improves small interfering RNA-induced thrombin receptor (PAR-1) gene silencing in DU 145 prostate cancer cells

1 reference

12 December 2020

Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression

1 reference

12 December 2020

Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis

1 reference

12 December 2020

A ribonuclease protection assay-based approach for analysis of angiogenic gene expression in archival tissues.

1 reference

12 December 2020

Thrombin receptor overexpression in malignant and physiological invasion processes

1 reference

12 December 2020

Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor.

1 reference

12 December 2020

Protease-activated receptors: contribution to physiology and disease

1 reference

12 December 2020

The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways

1 reference

12 December 2020

Expression of functional protease-activated receptor 1 in human prostate cancer cell lines

1 reference

12 December 2020

Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression

1 reference

12 December 2020

The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor

1 reference

12 December 2020

Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor

1 reference

12 December 2020

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

1 reference

12 December 2020

Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8

1 reference

12 December 2020

Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S10585-009-9301-8

Identifiers

DOI

1 reference

14 September 2017

1 reference